Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

June 19, 2025

Identification of the differences in molecular networks between idiopathic pulmonary fibrosis and lung squamous cell carcinoma using machine learning – ScienceDirect.com

June 9, 2025

Association of the MUC5B promoter polymorphism with idiopathic pulmonary fibrosis in a lebanese cohort – Frontiers

June 9, 2025

Cellular senescence-related gene signatures in idiopathic pulmonary fibrosis: insights from bioinformatics – Frontiers

June 4, 2025

Understanding Idiopathic Pulmonary Fibrosis: New Insights and Emerging Treatment Options – Frontiers

June 3, 2025

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial – Nature

34 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of August 23, 2025

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

WHAT IS

CONGRESS DOING?